RE-BVS – Piemonte Repository

Sfoglia per AUTORE
NOZZA S
Collezione ASL Città di Torino

Items : 22

Question and answers on long-acting therapy with cabotegravir and rilpivirine in people with HIV. in The Journal of antimicrobial chemotherapy / J Antimicrob Chemother. 2025 Mar 3;80(3):610-623. doi: 10.1093/jac/dkaf025.

2025
ASL Città di Torino

Lo Caputo S; Guaraldi G; Gianotti N; Di Biagio A; Cingolani A; Bonora S; Taramasso L; Madeddu G; Maggi P; Marchetti G; Nozza S; Rusconi S; Maggiolo F;

Serum and CSF biomarkers in asymptomatic patients during primary HIV infection: a randomized study. in Brain : a journal of neurology / Brain. 2024 Nov 4;147(11):3742-3750. doi: 10.1093/brain/awae271.

2024
ASL Città di Torino

Gulminetti R; Ripamonti D; Muscatello A; Antinori A; Gabrieli A; Rusconi S; Bruzzesi E; Trunfio M; Bernasconi D; Marchetti G; Cinque P; Cusato J; Calcagno A; Antonucci M; Nozza S;

Long-term outcomes of bictegravir/emtricitabine/tenofovir alafenamide as first-line therapy and as switch strategy in virologically suppressed persons with HIV: data from the ICONA cohort. in The Journal of antimicrobial chemotherapy / J Antimicrob Chemother. 2024 Jun 3;79(6):1279-1288. doi: 10.1093/jac/dkae081.

2024
ASL Città di Torino

d'Arminio Monforte A; Tavelli A; Di Biagio A; Sarmati L; Marchetti GC; Bai F; Cingolani A; Quiros Roldan E; Mussini C; Lichtner M; Vergori A; Piconi S; Orofino G; Fusco FM; Bandera A; Nozza S; Castagna A; Antinori A;

Preferences of PLWH and of clinicians for HIV treatment aimed at long-term success. in The new microbiologica / New Microbiol. 2022 Dec;45(4):308-319.

2022
ASL Città di Torino

Corbelli GM; Pasqualetti P; Teti E; Nozza S; Tavio M; Rizzardini G; Mastroianni C; Mussini C; Di Perri G; D'Arminio Monforte A; Castagna A; Antinori A; Andreoni M;

The challenge of infectious diseases consultations in the emergency department: an Italian nationwide survey. in The new microbiologica / New Microbiol. 2022 Dec;45(4):260-268. Epub 2022 Oct 3.

2022
ASL Città di Torino

Riccardi N; Antonello RM; Giacomelli A; Saderi L; Canetti D; Pallotto C; Mazzaferri F; Degli Antoni AM; Cardellino C; Motta I; Calcagno A; Falcone M; Trezzi M; Comelli A; Pascale R; Merli M; Binda F; Angheben A; Sotgiu G; Gobbi F; Nozza S;

Dolutegravir is not associated with weight gain in antiretroviral therapy experienced geriatric patients living with HIV. in AIDS (London, England) / AIDS. 2021 May 1;35(6):939-945. doi: 10.1097/QAD.0000000000002853.

2021
ASL Città di Torino

Guaraldi G; Calza S; Milic J; Calcagno A; Focà E; Rota M; Renzetti S; Celotti A; Siano M; Celesia BM; Piconi S; de Socio GV; Cattelan AM; Orofino G; Riva A; Nozza S; di Perri G;

Anti-Tat immunity defines CD4(+) T-cell dynamics in people living with HIV on long-term cART. in EBioMedicine / EBioMedicine. 2021 Apr;66:103306. doi: 10.1016/j.ebiom.2021.103306. Epub 2021 Apr 7.

2021
ASL Città di Torino

Tripiciano A; Picconi O; Moretti S; Sgadari C; Cafaro A; Francavilla V; Arancio A; Paniccia G; Campagna M; Pavone-Cossut MR; Sighinolfi L; Latini A; Mercurio VS; Pietro MD; Castelli F; Saracino A; Mussini C; Perri GD; Galli M; Nozza S; Ensoli F; Monini P; Ensoli B;

Durability of Integrase STrand Inhibitor (InSTI)-based regimen in geriatric people living with HIV in the GEPPO cohort. in PloS one / PLoS One. 2021 Oct 13;16(10):e0258533. doi: 10.1371/journal.pone.0258533. eCollection 2021.

2021
ASL Città di Torino

Focà E; Calcagno A; Calza S; Renzetti S; Chiesa A; Siano M; De Socio G; Piconi S; Orofino G; Madeddu G; Cattelan AM; Nozza S; Ferrara M; Milic J; Celesia BM; Castelli F; Guaraldi G;

Predictors of incomplete viral response and virologic failure in patients with acute and early HIV infection. Results of Italian Network of ACuTe HIV InfectiON (INACTION) cohort. in HIV medicine / HIV Med. 2020 Sep;21(8):523-535. doi: 10.1111/hiv.12885. Epub 2020 Jun 24.

2020
ASL Città di Torino

Taramasso L; Fabbiani M; Nozza S; De Benedetto I; Bruzzesi E; Mastrangelo A; Pinnetti C; Calcagno A; Ferrara M; Bozzi G; Focà E; Quiros-Roldan E; Ripamonti D; Campus M; Celesia BM; Torti C; Cosco L; Di Biagio A; Rusconi S; Marchetti G; Mussini C; Gulminetti R; Cingolani A; d'Ettorre G; Madeddu G; Franco A; Orofino G; Squillace N; Muscatello A; et alii...

Enhanced Immunological Recovery With Early Start of Antiretroviral Therapy During Acute or Early HIV Infection-Results of Italian Network of ACuTe HIV InfectiON (INACTION) Retrospective Study. in Pathogens & immunity / Pathog Immun. 2020 Feb 24;5(1):8-33. doi: 10.20411/pai.v5i1.341. eCollection 2020.

2020
ASL Città di Torino

Muscatello A; Nozza S; Fabbiani M; De Benedetto I; Ripa M; Dell'acqua R; Antinori A; Pinnetti C; Calcagno A; Ferrara M; Focà E; Quiros-Roldan E; Ripamonti D; Campus M; Maurizio Celesia B; Torti C; Cosco L; Di Biagio A; Rusconi S; Marchetti G; Mussini C; Gulminetti R; Cingolani A; D'ettorre G; Madeddu G; Franco A; Orofino G; Squillace N; Gori A; et alii...

Impact of genotypic susceptibility score on cART outcomes during primary HIV infection. in Journal of medical virology / J Med Virol. 2019 Oct;91(10):1891-1895. doi: 10.1002/jmv.25517. Epub 2019 Jun 27.

2019
ASL Città di Torino

Giacomelli A; Fabbiani M; De Benedetto I; Nozza S; Focà E; Celesia BM; Marchetti G; Mussini C; Antinori A; d'Ettorre G; Madeddu G; Bandera A; Muscatello A; Rusconi S;

Elderly HIV-positive women: A gender-based analysis from the Multicenter Italian "GEPPO" Cohort. in PloS one / PLoS One. 2019 Oct 17;14(10):e0222225. doi: 10.1371/journal.pone.0222225. eCollection 2019.

2019
ASL Città di Torino

Focà E; Magro P; Guaraldi G; Riva A; Cattelan AM; De Socio GV; Costa C; Piconi S; Celesia BM; Nozza S; Orofino G; Castagna A; Di Perri G; Castelli F; Calcagno A;

The increasing burden and complexity of multi-morbidity and polypharmacy in geriatric HIV patients: a cross sectional study of people aged 65 - 74 years and more than 75 years. in BMC geriatrics / BMC Geriatr. 2018 Apr 20;18(1):99. doi: 10.1186/s12877-018-0789-0.

2018
ASL Città di Torino

Guaraldi G; Malagoli A; Calcagno A; Mussi C; Celesia BM; Carli F; Piconi S; De Socio GV; Cattelan AM; Orofino G; Riva A; Focà E; Nozza S; Di Perri G;

Antiretroviral therapy in geriatric HIV patients: the GEPPO cohort study. in The Journal of antimicrobial chemotherapy / J Antimicrob Chemother. 2017 Oct 1;72(10):2879-2886. doi: 10.1093/jac/dkx169.

2017
ASL Città di Torino

Nozza S; Malagoli A; Maia L; Calcagno A; Focà E; De Socio G; Piconi S; Orofino G; Cattelan AM; Celesia BM; Gervasi E; Guaraldi G;

Proportion and factors associated with recent HIV infection in a cohort of patients seen for care in Italy over 1996-2014: Data from the ICONA Foundation Study cohort. in PloS one / PLoS One. 2017 Dec 5;12(12):e0189045. doi: 10.1371/journal.pone.0189045. eCollection 2017.

2017
ASL Città di Torino

Nozza S; Cozzi-Lepri A; Bai F; Rusconi S; Gori A; Cinque P; Ammassari A; Caramello P; Tambussi G; D'Arminio Monforte A; Marchetti G;

PrEP in Italy: The time may be ripe but who's paying the bill? A nationwide survey on physicians' attitudes towards using antiretrovirals to prevent HIV infection. in PloS one / PLoS One. 2017 Jul 20;12(7):e0181433. doi: 10.1371/journal.pone.0181433. eCollection 2017.

2017
ASL Città di Torino

Di Biagio A; Riccardi N; Signori A; Maserati R; Nozza S; Gori A; Bonora S; Borderi M; Ripamonti D; Rossi MC; Orofino G; Quirino T; Nunnari G; Celesia BM; Martini S; Sagnelli C; Mazzola G; Colletti P; Bartolozzi D; Bini T; Ladisa N; Castelnuovo F; Saracino A; Lo Caputo S;

Erratum to: Ageing with HIV: a multidisciplinary review. in Infection / Infection. 2015 Oct;43(5):627. doi: 10.1007/s15010-015-0808-4.

2015
ASL Città di Torino

Calcagno A; Nozza S; Mussi C; Celesia BM; Carli F; Piconi S; De Socio GV; Cattelan AM; Orofino G; Ripamonti D; Riva A; Di Perri G;

Ageing with HIV: a multidisciplinary review. in Infection / Infection. 2015 Oct;43(5):509-22. doi: 10.1007/s15010-015-0795-5. Epub 2015 May 19.

2015
ASL Città di Torino

Calcagno A; Nozza S; Muss C; Celesia BM; Carli F; Piconi S; De Socio GV; Cattelan AM; Orofino G; Ripamonti D; Riva A; Di Perri G;

An update on integrase inhibitors: new opportunities for a personalized therapy? The NEXTaim Project. in The new microbiologica / New Microbiol. 2015 Oct;38(4):443-90.

2015
ASL Città di Torino

Andreoni M; Marcotullio S; Puro V; De Carli G; Tambussi G; Nozza S; Gori A; Rusconi S; Santoro MM; Clementi M; Perno CF; d'Arminio Monforte A; Maggiolo F; Castagna A; De Luca A; Galli M; Giacomelli A; Borderi M; Guaraldi G; Calcagno A; Di Perri G; Bonora S; Mussini C; Di Biagio A; Puoti M; Bruno R; Zuccaro V; Antinori A; Cinque P; et alii...

Seminal pharmacokinetics and antiviral efficacy of once-daily maraviroc plus lopinavir/ritonavir in HIV-infected patients. in The Journal of antimicrobial chemotherapy / J Antimicrob Chemother. 2014 Sep;69(9):2586-8. doi: 10.1093/jac/dku142. Epub 2014 May 8.

2014
ASL Città di Torino

Calcagno A; Nozza S; Simiele M; Milia MG; Chiappetta S; D'Avolio A; Ghisetti V; Lazzarin A; Di Perri G; Bonora S;

Etravirine plasma exposure is associated with virological efficacy in treatment-experienced HIV-positive patients. in Antiviral research / Antiviral Res. 2014 Aug;108:44-7. doi: 10.1016/j.antiviral.2014.05.009. Epub 2014 May 23.

2014
ASL Città di Torino

Calcagno A; Marinaro L; Nozza S; Aldieri C; Carbone A; Ghisetti V; Trentalange A; D'Avolio A; Castagna A; Di Perri G; Bonora S;

Maraviroc is a substrate for OATP1B1 in vitro and maraviroc plasma concentrations are influenced by SLCO1B1 521 T>C polymorphism. in Pharmacogenetics and genomics / Pharmacogenet Genomics. 2010 Dec;20(12):759-65. doi: 10.1097/FPC.0b013e3283402efb.

2010
ASL Città di Torino

Siccardi M; D'Avolio A; Nozza S; Simiele M; Baietto L; Stefani FR; Moss D; Kwan WS; Castagna A; Lazzarin A; Calcagno A; Bonora S; Back D; Di Perri G; Owen A;